Blog

Butler promises public evaluation of pharmacy prescribing trial

Federal health minister Mark Butler has promised a “thorough, public” evaluation of the national pharmacy prescribing trial, acknowledging concerns about patient safety and the rapid expansion of pharmacists’ scope of practice across Australia.
Speaking at the RACGP’s GP26 conference in Adelaide this morning, Mr Butler was asked by newly elected college president Dr Ramya Raman whether he would commit to a clinically robust, independent and publicly available evaluation of pharmacy prescribing under the National Women’s Health Trial.
The question alone elicited strong applause from the audience, eclipsed only by his “Yes”.
Mr Butler acknowledged that pharmacy prescribing remained a highly contested issue and that state governments were moving at different speeds to expand pharmacists’ scope of practice.
“It’s changing so quickly,” he said.
He said health ministers had discussed the need for a more coherent framework for regulatory boards considering scope-of-practice expansions.
“I completely understand that there is concern about this in the medical community and not just from a territorial perspective, [but also] from a quality care perspective,” he said.
However, he acknowledged arguments about improving access to care, particularly for uncomplicated urinary tract infections on weekends.
Mr Butler said the 12-month national trial, covering uncomplicated UTIs and contraception, was essentially a payment arrangement for services already available under state arrangements.
“And yes, I’m very, very much committed to a thorough evaluation, which will be public,” he said.
He did not explicitly confirm whether the evaluation would be independent.
Time-tiered consultation reform on the agenda
Mr Butler also signalled that reform of Medicare’s time-tiered GP consultation items would be a priority in coming months, with the final report of the MBS Review Advisory Committee’s review expected before Christmas.
He acknowledged calls from the RACGP and Australian Medical Association to reconsider the structure of consultation rebates to better reflect increasingly complex patient presentations.
Dr Raman told the minister that GPs were struggling to manage patients with multiple conditions within standard 15- to 20-minute appointments.
Mr Butler said the introduction of the level E consultation item had helped patients requiring extended appointments, but recognised concerns about the structure of rebates for other consultations.
“I’m up for that,” he said of restructuring the existing arrangements.
He said the government had prioritised affordability and bulk billing during its first years in office, rather than broader structural reforms.
“I think we’re in a position to look for reform,” he said.
Mr Butler acknowledged that the Medicare Benefits Schedule had been designed around a very different model of general practice in the 1980s.
He also identified the menopause health assessment and heart health assessment as items worth reviewing to ensure they adequately supported patient care.
GPs could take on work currently reserved for specialists
Mr Butler raised the possibility of expanding GPs’ scope of practice as part of the government’s efforts to address rising out-of-pocket costs charged by non-GP specialists.
He said patients’ out-of-pocket payments for non-GP specialist care had approximately doubled over the past seven years.
According to the minister, about 1.5 million out-of-pocket charges were between three and five times the average charged by other specialists, while 220,000 procedures each year attracted charges more than five times the average.
“That is difficult to explain. That is difficult to rationalise,” he said.
Mr Butler said the government was considering changes to referral arrangements and ways to introduce greater competition into parts of the specialist sector.
“There’s a lot of work that’s preserved to non-GP specialists that GPs could very rightly be doing if they choose to,” he said.
He described the AMA’s submission to the scope-of-practice review as positive in this regard and said he wanted further discussions with the RACGP.
Independent Medicare pricing not ruled out
The minister also left open the possibility of introducing an independent authority to determine Medicare rebates, although he warned that such a move would have substantial budget implications.
Dr Raman challenged Mr Butler over this year’s 2.6% Medicare indexation increase, which she said was below CPI and healthcare inflation.
She argued that general practice was already going backwards despite the government’s Medicare investments and asked whether independent pricing could better reflect the real cost of delivering care.
Mr Butler acknowledged the issue but cautioned against expecting an immediate commitment.
“That would be a big step. I’m not going to gild the lily on this. It would be a very big step for government to make,” he said.
He pointed to the introduction of independent pricing arrangements for hospitals and aged care, as well as his previously expressed willingness to consider a similar model for the NDIS.

Related   

Pharmacy guild produces new prescribing claims

AMA warns pharmacy prescribing undermines AMR stewardship

When do we admit that the guild has won?

“We’ve not made a final decision about this,” he said.
“I don’t want to say never,” he added, noting that independent pricing had become more common across health and social care programs.
Mr Butler said he had not yet received final advice arising from work involving the department and sector representatives.
He welcomed further discussion but described independent Medicare pricing as “a very big budget ask”.
Growing complexity putting pressure on GPs
Throughout his address, Mr Butler acknowledged the increasing demands being placed on general practice, particularly as GPs managed more complex chronic conditions and mental health presentations.
He compared the pressures on GPs with those experienced by teachers, who were continually being asked to take on additional responsibilities in response to broader social problems.
“In the healthcare system, we’re constantly saying GPs just have to do a little bit more,” he said.
Mr Butler said governments had a responsibility to provide greater support as those demands increased.
He pointed to mental health as an increasingly significant component of general practice, particularly among younger Australians.
Dr Raman said that, in her own clinical practice, one in three patients raised a mental health concern during consultations.
Mr Butler also highlighted the government’s progress on bulk billing, saying rates had increased by six percentage points over the previous 12 months and that more than 4000 practices had signed up to the bulk billing practice incentive.
He said the government was progressing faster than expected towards its target of 90% bulk billing by 2030.
However, he acknowledged that some communities were not experiencing the same improvements in access and affordability as others.
The minister said the next stage of reform needed to ensure GPs were supported to deliver care that had become substantially more complex than when much of Medicare’s original structure was developed.
GP26 is on in Adelaide from 20 to 22 November 2026.
The post Butler promises public evaluation of pharmacy prescribing trial appeared first on Medical Republic.

About the author

Asonblog

Add Comment

Click here to post a comment